Table 2. Summary of findings including GRADE quality assessment for comparison between combine formulation of olive leaf extract and placebo.
| No. of participants | Anticipated absolute effects* | |||||||
|---|---|---|---|---|---|---|---|---|
| Outcomes | No. of participants (studies) | placebo | combined formulation of 1,000 mg of olive leaf extract per day | MD | 95% CI | P-value | Certainty of the evidence (GRADE) | Comments |
| Systolic blood pressure (mmHg) | 37 (1 RCT) | 19 | 18 | 0.54 lower | −4.76 to 3.68 | 0.80 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b indirectness: not serious; imprecision: seriousa; |
| Diastolic blood pressure (mmHg) | 37 (1 RCT) | 19 | 18 | 0.49 lower | −2.75 to 1.77 | 0.67 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| Total cholesterol (mg/dl) | 37 (1 RCT) | 19 | 18 | 9.66 higher | −2.15 to 21.47 | 0.11 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| LDL (mg/dl) | 37 (1 RCT) | 19 | 18 | 0 | −12.52 to 12.52 | 1.00 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| HDL (mg/dl) | 37 (1 RCT) | 19 | 18 | 1.16 higher | −1.55 to 3.87 | 0.40 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| TG (mg/dl) | 37 (1 RCT) | 19 | 18 | 46.87 higher | −0.38 to 94.12 | 0.05 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| HOMA-IR | 37 (1 RCT) | 19 | 18 | 0.4 higher | 0.27 to 0.53 | <0.001 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| Fasting blood glucose (mmol/l) | 37 (1 RCT) | 19 | 18 | 0.01 higher | −0.21 to 0.23 | <0.93 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
| Insulin (µu/ml) | 37 (1 RCT) | 19 | 18 | 1.08 higher | 0.56 to 1.6 | <0.001 | ⊕⊕ LOWa,b | Risk of bias: not serious Inconsistency: seriousa,b; indirectness: not serious; imprecision: seriousa; |
Notes.
The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
- CI
- Confidence interval
- MD
- Mean difference
Explanations
small population
wide CI
GRADE Working Group grades of evidence.
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.